Cargando…
Cerebrospinal fluid penetration of very high-dose meropenem: a case report
BACKGROUND: Standard dosing of meropenem (2 g t.i.d.) produces CSF concentrations of only 1–2 mg/L which is inferior to the clinical breakpoint for most Gram-negative bacteria. There is therefore concern that dosing must be increased in order to achieve therapeutic CSF concentrations for bacteria wi...
Autores principales: | Kerz, Thomas, von Loewenich, Friederike D., Roberts, Jason, Neulen, Axel, Ringel, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310956/ https://www.ncbi.nlm.nih.gov/pubmed/30594199 http://dx.doi.org/10.1186/s12941-018-0299-0 |
Ejemplares similares
-
Continuous Intraarterial Nimodipine Infusion for the Treatment of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Retrospective, Single-Center Cohort Trial
por: Kramer, Andreas, et al.
Publicado: (2022) -
Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study
por: Blassmann, Ute, et al.
Publicado: (2016) -
Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery
por: Lu, Cheng, et al.
Publicado: (2016) -
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
por: Tiede, Christoph, et al.
Publicado: (2021) -
Cerebrospinal fluid penetration of linezolid in neurosurgical patients
por: Myrianthefs, P, et al.
Publicado: (2006)